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Abstract
Background: Bovine theileriosis caused by Theileria orientalis is an emerging disease of cattle in the Asia-Pacific
region where it causes a significant economic burden to meat and milk production. While host immunological
responses to the lymphocyte-transforming species of Theileria, T. parva and T. annulata, have been well studied,
little is known about the immune response to this non-transforming species.
Methods: We developed a recombinant antigen ELISA based on the major piroplasm surface protein (MPSP) of T.
orientalis and investigated whether seroconversion to the MPSP was associated with clinical factors (anaemia),
parasite burden and parasite genotype. We also examined the dynamics of seroconversion in animals acutely
infected with T. orientalis.
Results: In cattle testing qPCR positive for T. orientalis, seroconversion was more frequent in anaemic compared to
normal cattle (P < 0.0001). The ELISA ratio (ER) was highly correlated with total parasite burden as measured by
qPCR (r = 0.69; P < 0.0001); however when loads of individual genotypes of the parasite were examined, only the
pathogenic Ikeda genotype was highly correlated with ER. Conversely, seroconversion was less frequently detected
in the presence of benign T. orientalis genotypes. Temporal measurement of the serological response, parasite
burden and packed cell volume (PCV) in acutely infected animals revealed that seroconversion to the MPSP occurs
within 2-3 weeks of the initial qPCR detection of the parasite and coincides with a peak in infection intensity and a
declining PCV.
Conclusion: Whether the serological response to the MPSP is immunoprotective against re-infection or
recrudescence requires further investigation; however the MPSP represents a promising target for a subunit vaccine
given that genetic variability within the MPSP results in differential pathogenicity of T. orientalis.
Keywords: Theileria orientalis, Major piroplasm surface protein (MPSP), Seroconversion, Anaemia, Genotype
Background
Theileria orientalis is an emerging apicomplexan patho-
gen of cattle in the Asia-Pacific region. Previously de-
scribed as benign, this haemoprotozoan is now
recognised as a disease of production cattle causing an-
aemia and ill-thrift. Mortalities of up to 5 %, particularly
in pregnant heifers and calves, have been reported and
the disease is also commonly associated with late term
abortion. The bush tick Haemaphysalis longicornis is
recognised as the vector for disease transmission [1, 2],
and the geographic distribution of recent bovine theiler-
iosis cases in Australia and New Zealand closely follow
the known range of this species [2, 3].
Many recent studies have focussed on identification and
differentiation of various genotypes of T. orientalis. These
genotypes are defined based on sequence variations in the
gene encoding the major piroplasm surface protein
(MPSP), an immunodominant antigen expressed during
both sporozoite and piroplasm phases of the T. orientalis
life-cycle [4]. While eleven genotypes of T. orientalis have
been identified globally (Types 1-8 and N1-N3) [5], dis-
ease outbreaks in cattle have been largely limited to Type
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2 (Ikeda genotype) [6–9], with only occasional reports of
clinical cases linked to other genotypes [10, 11]. Genotype
3 (Buffeli) [6, 7, 12] and its phylogenetic relative, Type 5
[7] have also been identified in Australian cattle, but these
genotypes have not been associated with clinical disease
and are considered benign.
Like other apicomplexans [13, 14], T. orientalis infec-
tion most frequently presents as a mixture of genotypes,
which likely facilitates evasion of the host immune sys-
tem [15–17]. Indeed, infected cattle appear to retain the
parasite for lengthy periods, perhaps for life [15]. Sub-
clinical infections with T. orientalis including the Ikeda
genotype are common [18] however; the immune mech-
anisms responsible for disease resistance are poorly
understood. Naïve cattle introduced to areas where the
disease is enzootic, as well as stressed, immunocom-
promised, pregnant or lactating animals are most at risk
of developing clinical disease [6, 12, 19], while cattle in
T. orientalis-endemic areas appear to develop a degree
of resistance to disease. It is unclear whether the host
develops a humoral response against the parasite prior
to the intra-erythrocytic phase of the parasite’s life-cycle,
or whether the immune response is largely cell-
mediated. Prior studies on T. annulata and T. parva
suggest that responses against these parasites are largely
cell-mediated [20, 21], however these organisms repre-
sent transforming theilerias which cause a tumour-like
lymphocytic proliferation [22] not observed in T. orien-
talis infection.
In T. orientalis, the MPSP is highly expressed during
both the sporozoite [4] and piroplasm [23] phases of the
parasite’s life-cycle and is believed to mediate entry into
bovine erythrocytes via interactions with heparin-like
compounds on the host cell surface [24]. Immunoblots
using sera from infected animals indicate that the MPSP
is strongly recognised by host IgG and that immunisa-
tion of cattle with MPSP is at least partially protective
against T. orientalis [25]. Nonetheless, immune re-
sponse to this antigen has not yet been quantified in
cattle using ELISA, although this method was found
to be a sensitive means of detecting T. orientalis in-
fection in water buffalo [26].
In this study, we developed a recombinant MPSP
ELISA to measure bovine IgG response to this major
surface antigen and correlate this response with clinical
disease, parasite genotype and infection intensity.
Methods
Samples
A total of 430 EDTA blood samples and their matching
sera were analysed in this study. Of these, 280 pairs of
samples were collected by private and district veterinar-
ians from 21cattle herds from the states of New South
Wales (NSW) and Queensland (QLD), Australia. These
samples were collected as part of routine clinical investi-
gations into the significance of the Theileria orientalis
genotypes in Australian cattle [12] or were submitted to
the Elizabeth Macarthur Agricultural Institute as clinical
samples from suspect theileriosis cases [6]. A further 60
pairs of samples served as negative controls; 50 of these
were collected from cattle herds located in regions
known to be free of T. orientalis and a further 10 pairs
of samples were derived from cattle infected with Babe-
sia bigemina (n = 3), Babesia bovis (n = 4) or Anaplasma
centrale (n = 3). The remaining pairs of samples (n = 90)
were collected from a single herd of 10 naïve animals
(2 year- old Ayrshire heifers) that had been introduced
to a property on the mid-coast of NSW with a history of
clinical theileriosis cases [16]. Briefly, EDTA blood was
collected from each animal immediately upon introduc-
tion to the affected property, and approximately weekly
thereafter for a period of 76 days [16]. Sera were pre-
pared from clotted blood or where clotted blood was un-
available; plasma was prepared from blood containing
anti-coagulant. These samples were used for a temporal
study examining seroconversion to the T. orientalis
MPSP.
Packed cell volume and blood films
Of the EDTA blood samples collected, 256 were exam-
ined for packed cell volume and 376 were examined via
blood film, as described previously [12, 16]. Animals
with a PCV < 24 % were considered anaemic.
Cloning and expression of the T. orientalis MPSP genes
MPSP genes amplified from each of the T. orientalis
Ikeda, Chitose and Buffeli MPSP types which had been
cloned into the Champion pET100 D-TOPO expression
vector (Invitrogen, Carlsbad, California, USA) [27] were
used to express recombinant antigen for Western blot-
ting and ELISA assays. The recombinant proteins were
purified using nickel affinity chromatography and dia-
lysed as previously described [28].
Western blotting
Western blots of recombinant MPSP antigen derived
from three genotypes of T. orientalis (Ikeda, Chitose
and Buffeli; predicted sizes 34-35 kDa) were screened
with antisera from cattle previously confirmed PCR
positive for a single MPSP genotype [6, 12]. The blots
were performed as described previously [29], except
that 1 μg of each MPSP protein was blotted against a
1:100 dilution of each primary antiserum. The sec-
ondary antibody was a 1:20 000 dilution of alkaline
phosphatase-conjugated anti-bovine (Sigma Aldrich, St
Louis, Missouri USA; Catalogue number A7554).
Blots were developed using NBT/BCIP substrate
(Sigma, Catalogue number 11697471001).
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ELISA
The recombinant MPSP ELISA was performed using a
cocktail of Ikeda, Chitose and Buffeli MPSP antigen at
equimolar concentrations as described previously [27],
except that 0.75 μg of total antigen (ie: 0.25 μg of each
antigen) was used to coat the ELISA plate wells. A 1 ×
Blocking Buffer solution (Cat. No. B6429; Sigma, St.
Louis, MO, USA) was used to block the plates and as an
antibody diluent. All washes were performed as de-
scribed previously [27] but using phosphate buffered sa-
line containing 0.05 % Tween 20 (PBST). Results were
expressed as an ELISA ratio (ER: mean OD610 test
serum/mean OD610 of the negative control serum). Sera
with an ER < 2 were considered negative, an ER ≥ 2 as
positive.
DNA extraction and quantitative PCR (qPCR)
DNA extractions were performed using the DNeasy
Blood and Tissue DNA extraction kit (Qiagen). All DNA
extractions and quantitative PCRs for T. orientalis (uni-
versal) and the genotypes Ikeda and Chitose (UIC qPCR)
were performed as previously described [30].
Statistical analysis
Associations between PCV and ELISA ratio and parasite
load and ELISA ratio were analysed using Spearman’s
rank correlation (r) for non-parametric data within
Prism 4 (GraphPad Software Inc., La Jolla, California,
USA). Fisher’s exact test (GraphPadQuickCalcs:http://
www.graphpad.com/quickcalcs/) was used to determine
whether there was an association between serological
status and clinical presentation (anaemic vs normal).
The probability that infection level was related to sero-
logical status was determined using the Freeman-Halton
extension of the Fisher’s exact test via the VassarStats
website (http://vassarstats.net/fisher2x3.html). P values
calculated for both tests are two-tailed.
Results
Immunological cross-reactivity between genotype MPSPs
While the MPSP gene is the most commonly used
marker to discriminate between the various T. orientalis
genotypes, the proteins encoded by these genes display a
high degree of sequence conservation. Studies using na-
tive and recombinant MPSP proteins have shown con-
flicting results with respect to serological cross-reactivity
between genotype MPSPs, with native [31] but not re-
combinant [32, 33] antigen being serologically distinct
amongst genotypes. Nonetheless, recombinant MPSPs
can be discriminated using monoclonal antibodies
against specific epitopes [32], while post-translational
modifications are believed to be responsible for sero-
logical discrimination amongst native MPSPs [33].
Western blotting of recombinant MPSP antigen from
the Ikeda, Chitose and Buffeli genotypes of T. orientalis
was undertaken to determine whether there was sero-
logical cross-reactivity between the genotype MPSPs
generated in this study. Sera from animals infected with
individual genotypes of the parasite (Ikeda, Chitose or
Buffeli as determined by qPCR) displayed cross-
reactivity with all three MPSP types (representative blots
are shown in Fig. 1). However, some variability in the re-
activity of serum in detecting their specific targets was
observed based on the intensity of the bands detected
(Fig. 1); therefore the MPSP antigens were pooled for
subsequent use in the ELISA assay.
Specificity and sensitivity of the MPSP ELISA
The specificity and sensitivity of the MPSP ELISA com-
pared to blood film examination and qPCR was assessed
A B C
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D
Fig. 1 Western blot analysis of recombinant MPSP antigens from the Ikeda (Lane 1), Chitose (Lane 2) and Buffeli (Lane 3) genotypes of T.
orientalis. One microgram of each recombinant protein was run on an 1D SDS-PAGE gel and stained (a) or blotted against sera from animals
infected with the Ikeda (b), Chitose (c) and Buffeli (d) genotypes of T. orientalis. Immunoreactive MPSP proteins are indicated with arrowheads.
M =molecular weight marker (sizes 250, 130, 100, 75, 55, 35 and 25 kDa).
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using 376 pairs of EDTA bloods and sera for which all
three assays had been conducted. PCR assays are consid-
ered a gold standard for T. orientalis detection, and con-
sistent with this, the UIC qPCR detected the highest
number of positive samples (262/376). Using qPCR as a
gold standard for comparison, the MPSP ELISA had a
sensitivity of 68.7 % and a specificity of 99.1 %, while
blood film examination had a sensitivity of 62.2 % and a
specificity of 97.4 %. Animals that were PCR positive but
ELISA negative either may have not yet seroconverted to
the MPSP antigen or did not elicit a strong enough
humoral response to enable detection. Thus, while
ELISA was found to be more sensitive and specific for T.
orientalis detection than blood film, as previously dem-
onstrated for T. orientalis detection in buffalo [26],
PCR-based methods remain the most sensitive option
for parasite detection.
MPSP seropositivity is associated with anaemia
Packed cell volume (PCV) was used as a measure of
clinical status and was compared to the corresponding
serological data from individual animals. Of the animals
with a PCV in the normal range (PCV ≥ 24), 55 % were
seronegative, while the majority of animals (89 %) with
anaemia were MPSP seropositive (Table 1). Fisher’s exact
test indicated that the association between MPSP sero-
positivity and anaemia was significant (P < 0.0001).
When the ELISA ratios of individual animals were plot-
ted against the corresponding PCVs a statistically signifi-
cant moderate and negative correlation (r = -0.5) was
observed (Fig. 2).
MPSP seropositivity is associated with total parasite load
and the Ikeda genotype
The parasite load within the blood of individual animals
was measured using the universal (T. orientalis) compo-
nent of a multiplex quantitative PCR assay [30]. Because
T. orientalis infections often present as a mixture of ge-
notypes, the relative quantities of the genotypes previ-
ously reported to be associated with clinical disease
(Ikeda and Chitose genotypes) were also measured using
the Ikeda and Chitose-specific components of the multi-
plex qPCR [30]. A Buffeli-specific qPCR was also used
to measure the quantities of this genotype [16]. The rela-
tionship between the MPSP ELISA ratio and the total
number of T. orientalis gene copies per μL of blood
(GC/μL) or those of the individual T. orientalis geno-
types is shown in Fig. 3. We observed a strong and signifi-
cant positive correlation between the load of T. orientalis
and the MPSP ELISA ratio (r = 0.69, P < 0.0001; Fig. 3a).
Comparison of individual genotype load with MPSP
ELISA ratio revealed a strong positive correlation for the
Ikeda genotype only (r = 0.71, P < 0.0001; Fig. 3b). There
was a weak but significant correlation (r = 0.15) be-
tween the MPSP ELISA ratio and the Chitose geno-
type (p = 0.02; Fig. 3c). No relationship was observed
between the quantity of the Buffeli genotype and
MPSP ELISA ratio (r = 0.02, p = 0.9; Fig. 3d).
The T. orientalis qPCR data were divided into three
categories of infection intensity (low medium and high)
based on previously established clinical thresholds [30].
Only 35 % of animals with infections in the low category
(<15 000 MPSP GC/μL), which typically represent sub-
clinical carriers, were MPSP seropositive. Animals in the
moderate (>15 000 but <300 000 MPSP GC/μL) cat-
egory, which usually represent recovering, in-contact or
clinically-affected animals, had a much higher rate of
MPSP seropositivity at 75 %. In a previous study,
92 % of animals in the high infection intensity range
were shown to have one or more signs of clinical
theileriosis [30]; 83 % of animals in this category
tested seropositive (Table 2).
Temporal dynamics of MPSP seroconversion
We examined the temporal dynamics of seroconversion
to the T. orientalis MPSP antigen by testing paired sera
and EDTA blood from 10 naïve cattle that were intro-
duced to a property with a known history of clinical
theileriosis cases. qPCR was used to monitor the pro-
gress of infection and the serological response to the
MPSP antigen was measured by MPSP ELISA. The PCV
Table 1 Frequency of anaemic versus normal animals in
relation to MPSP serological status
Anaemic (n = 36) Normal (n = 220)
MPSP seropositive 32 (89 %) 98 (45 %)
MPSP seronegative 4 (11 %) 122 (55 %)
P < 0.0001















Fig. 2 The ELISA ratios (ER) of individual animal sera are negatively
correlated with the packed cell volume (PCV) of whole
blood (r = -0.5).
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of each animal was also tested. All animals became rap-
idly infected with T. orientalis following introduction to
the affected property, with 7 animals testing qPCR posi-
tive by Day 11 post-introduction and the remaining 3
animals testing positive by Day 20. The average peak in
parasite load was at Day 40 post-introduction (Fig. 4a).
In contrast, a positive serological response to the MPSP
antigen was detected in only 1 animal at Day 20 post-
introduction (this animal was qPCR positive at Day 11);
however all 10 animals had seroconverted by Day 34
(Fig. 4b). The peak serological response occurred be-
tween Days 34 and 40 and preceded a sharp drop in
parasite load between Days 40 and 48. The MPSP sero-
logical response declined steadily from Day 40 until the
end of the sampling period (Day 76); however all ani-
mals remained in the positive range over this period.
The average PCV of the cattle began to drop on Day 20,
shortly after or coinciding with the onset of infection,
and reaching a trough between Days 40 and 54 (Fig. 4c).
All animals except one entered the anaemic range fol-
lowing the peak in infection intensity and the MPSP
antibody response. In 9/10 cows, the decline in PCV
commenced prior to the animals returning their first
seropositive result; in the remaining animal, the decline
in PCV coincided with the first seropositive result on
Day 20; however at this time the animal was only just
over the positive ER threshold of 2.
Discussion
The drivers of the host immunological response to T.
orientalis infection are poorly studied but require inves-
tigation if effective vaccines are to be developed against
this parasite in the future. Here we examined factors as-
sociated with stimulation of a humoral response to a
major surface protein (MPSP) of T. orientalis which is
expressed during both the merozoite (piroplasm) and
sporozoite life-cycle phases of the parasite. The sero-
logical status of T. orientalis-infected animals is of





Fig. 3 (a) The total parasite load (gene copies/μL of blood) as measured by qPCR is positively correlated with the ELISA ratio (ER). Levels of the
Ikeda genotype are strongly correlated with ER (b), while the levels of the Chitose genotype are only weakly correlated (c). No correlation was
observed between levels of the Buffeli genotype and ER (d).
Table 2 Relationship between infection level and serological status
Infection level*
High (n = 12) Moderate (n = 106) Low (n = 110)
MPSP seropositive 11 (83 %) 80 (75 %) 39 (35 %)
MPSP seronegative 1 (17 %) 26 (25 %) 71 (65 %)
P < 0.0001
*Infection levels are as defined in [30]. Low: <15 000 gene copies/μL blood; Moderate: >15 000 but <300 000 gene copies/μL blood; High: >300 000 gene
copies/μL blood.
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interest given a potential role for humoral immunity in
the host response to infection. While humoral responses
to intracellular pathogens have traditionally been consid-
ered of less importance than cell-mediated responses,
there are many recent examples where antibodies
have been found to afford protection by acting in
concert with the cellular immune system or by neu-
tralising extracellular phases of the pathogen prior to
gaining cell entry [34].
While the host response to infection in the transform-
ing Theileria spp. (T. parva and T. annulata) appears to
be largely mediated by cytotoxic T cell responses against
macroschizont-infected lymphoblasts [35]; T. orientalis
lacks the ability to transform leukocytes. In contrast, the
pathogenic phase of T. orientalis is the intraerythrocytic
phase, with the major symptoms of disease resulting
from erythrocyte destruction and subsequent anaemia.
In this study we found a significant association between
MPSP seropositivity and anaemia with 89 % of anaemic
animals seroconverting to the MPSP antigen. Con-
versely, only 45 % of animals with PCVs in the normal
range had seroconverted. While seroconversion to T.
parva shows a small but significant inverse association
with PCV, the association between anaemia and sero-
conversion to the tick fever parasite, Babesia bigemina is
much more marked [36]. Like T. orientalis, B. bigemina
is a non-transforming member of the Piroplasmida,
exerting its major pathogenic effects via its intraerythro-
cytic phase [37]. Thus, it appears that in both B.
bigemina and T. orientalis infection, seroconversion is
linked to erythrocyte destruction. This observation was
consistent with data from our temporal study in which
10 naïve cows became acutely infected with T. orientalis.
In these animals, seroconversion to the MPSP antigen
had already occurred (Day 34) by the time the parasite
load peaked (Day 40). Furthermore, while the animals
did not become anaemic until approximately 10 days
after parasite load and serological response had peaked,
the onset of the decline in PCV commenced very early
in the time course (Day 20 on average). In addition,
9 of 10 animals were seronegative on Day 20, despite the
fact that the majority of animals tested qPCR positive
for T. orientalis by Day 11. Furthermore, in a prior study
using a T. orientalis ELISA based on crude whole anti-
gen, the onset of the serological response coincided with
the appearance of the piroplasm phase in red blood cells
[38]. Together, these data suggest that seroconversion
may occur as a consequence of the release of free para-
sites/parasite antigen from lysed erythrocytes rather than
in response to the initial inoculation of sporozoites from
the tick. Indeed prior studies on Theileria spp. indicate
that the sporozoites become rapidly internalised (within
3 minutes) of cell attachment [39].
In this study, we revealed a strong, positive and signifi-
cant correlation between the MPSP ELISA ratio and the
total parasite load as determined by qPCR. Furthermore,
when the levels of the individual T. orientalis genotypes
were examined, the correlation was strongest (r = 0.71)

















Fig. 4 Temporal dynamics of T. orientalis infection as determined by qPCR (a), MPSP serological response (b) and packed cell volume (c) in 10
naïve animals introduced to a property with a history of clinical theileriosis. Parasite load and serological response peaked between Day 34 and
40 post introduction (a& b), after which time the antibody titre declined sharply but remained above the ELISA positive cut-off (dotted line). The
PCV of the infected animals began to decline at Day 20 post-introduction (c), with animals falling into the anaemic range between Day 40 and
Day 48 post-introduction. All graphs show the mean and range of data from the 10 animals.
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with the load of the T. orientalis Ikeda genotype. The
Ikeda genotype has been linked to many clinical out-
breaks of bovine theileriosis in the Asia-Pacific region
[7–9, 12] and is considered the major pathogenic geno-
type of this parasite. In contrast the levels of the Chitose
and Buffeli genotypes, which are very rarely associated
with disease, showed only a weak or no correlation with
the MPSP ELISA ratio respectively. We demonstrated in
a prior study that the Ikeda genotype of T. orientalis is
frequently associated with high infection intensities and
furthermore, that infection intensity is negatively corre-
lated with PCV [30]. The decline in PCV resulting from
T. orientalis Ikeda infection reflects enhanced erythro-
cyte destruction in the presence of this genotype and
consequently, the increased likelihood of a serological
response associated with infection by this genotype.
Results from our temporal study indicated that ani-
mals acutely infected with T. orientalis seroconverted 2-
3 wk after the parasite was detectable via qPCR (34 days
post-introduction to the affected herd). This is directly
comparable to a study on the tick fever parasites, Babe-
sia bovis and B. bigemina, in which animals introduced
to a property with ticks harbouring these parasites all
seroconverted within 35 days, coinciding with a decline
in their PCVs [40]. Nonetheless, tick-borne parasites
vary in their ability to induce a sustained serological re-
sponse in their hosts. Animals acutely infected with T.
parva may die prior to seroconversion; however surviv-
ing animals tend to produce a long-lasting serological
response and are generally immune to re-infection
thereafter [41]. While the longevity of the serological re-
sponse to Babesia spp. is variable, seropositivity is often
sustained for between 18 months and 6 years [37, 40,
42]. In contrast, Theileria mutans induces only short-
term serological responses [41]. In the case of T. orienta-
lis, we demonstrated that the antibody titre declines
steeply (along with the parasite burden) following acute
infection; however in all animals examined, the MPSP
serological response plateaued within the positive range
for the remainder of the study period (76 days). Whether
the serological response is sustained over the longer
term is yet to be determined.
While cell-mediated responses are central to protec-
tion from re-infection with the transforming theilerias
[5, 21, 43] the pathogenesis of T. orientalis more closely
resembles that of the non-transforming piroplasmids, B.
bovis and B. bigemina. Bigemina bovis infection is con-
comitant: animals remain persistently infected with the
parasite, but resist disease relapse [44]. While T. orienta-
lis infections are known to persist long-term [15], it is
currently unclear whether acutely infected animals be-
come refractory to subsequent disease. In B. bovis infec-
tion, immune protection appears to involve a
combination of innate and cell-mediated immunity and
neutralising antibody [44]. The spleen is central to the
host response to acute disease and removes parasitised
erythrocytes from circulation, while subsequent stimula-
tion of CD4+ T lymphocytes and the production of neu-
tralising antibody appear to be responsible for
subsequent adaptive immunity to the parasite. The
spleen is evidently of similar importance in respond-
ing to acute theileriosis caused by T. orientalis, with
splenomegaly a common finding on necropsy [19]
and splenectomy inducing high parasitaemias in in-
fected animals [45]. Indeed, splenic clearance of para-
sitised erythrocytes is most likely responsible for the
declines in PCV observed in acutely affected animals
in this study and the spleen may also be important in
the generation of the serological response via the
white pulp.
In B. bovis infection, antibodies are believed to be
most important in neutralising extracellular phases of
the parasite including the sporozoite and merozoite
phases, and in capturing erythrocytes expressing parasite
antigen on the cell surface [44]. In some cases, immunity
to Babesia infection only appears to occur following
seroconversion [37, 46, 47]. Whether the humoral re-
sponse to the T. orientalis MPSP protects against recru-
descence or re-infection with new T. orientalis strains
remains unclear, but is worthy of further investigation.
Indeed, one study suggested that passive transfer of
monoclonal antibodies raised against MPSP epitopes
had an immunoprotective effect on calves challenged
with T. orientalis [48]. Similarly, calves vaccinated with
either recombinant MPSP antigen or peptides derived
from the MPSP antigen showed reduced parasitaemias
and an absence of clinical signs of disease relative to
control calves following experimental challenge [25].
Further investigation of the T. orientalis MPSP as a po-
tential candidate for a subunit vaccine is worthwhile due
to the promising results from these initial investigations.
While live vaccines are generally favoured for the pre-
vention of apicomplexan infections due to high levels of
genetic variation within these organisms, T. orientalis
may represent a unique case given that a single MPSP
genotype (Ikeda) is correlated with the majority of clin-
ical outbreaks.
Conclusions
We demonstrate that seroconversion to the T. orien-
talis MPSP is significantly associated with host an-
aemia, parasite load and parasite genotype. Acutely
infected animals seroconvert quickly (within 2-3
weeks post-infection) and the humoral response to
the parasite is maintained for at least 10 weeks. The
T. orientalis MPSP should be further considered as a
vaccine target for the prevention of bovine theileriosis
in the Asia-Pacific.
Jenkins and Bogema Parasites & Vectors  (2016) 9:106 Page 7 of 9
Competing interests
The authors declare that they do not have competing interests.
Authors’ contributions
CJ conceived the study and with DB, designed the study. CJ performed the
serology and DB performed the qPCR analyses. CJ performed the statistical
analyses and drafted the manuscript and DB revised the manuscript. Both
authors read and approved the final manuscript.
Acknowledgements
This work was funded by grants to CJ from Meat and Livestock Australia
(Project B.AHE.0213) and the McGarvie Smith Institute. We are grateful for
the technical assistance of Jocelyn Gonsalves and Melinda Micallef who
assisted in running the ELISA and qPCR assays. We also acknowledge Dr
Graeme Eamens who provided helpful advice on the ELISA development
and to the numerous district and private veterinarians who submitted the
samples used in this study.
Author details
1NSW Department of Primary Industries, Elizabeth Macarthur Agricultural
Institute, Menangle, NSW 2568, Australia. 2The ithree institute, University of
Technology, Sydney, Ultimo, NSW 2007, Australia.
Received: 26 November 2015 Accepted: 20 February 2016
References
1. Fujisaki K, Ito Y, Kamio T, Kitaoka S. The presence of Theileria sergenti in
Haemaphysalis longicornis overwintering in pasture in Japan. Ann Trop Med
Parasitol. 1985;79(5):519–24.
2. Hammer J, Emery D, Bogema DR, Jenkins C. Detection of Theileria orientalis
genotypes in Haemaphysalis longicornis ticks from southern Australia. Parasit
Vectors. 2015;8:229.
3. Heath A. Biology, ecology and distribution of the tick, Haemaphysalis
longicornis Neumann (Acari: Ixodidae) in New Zealand. N Z Vet J. 2016;64(1):
10–20.
4. Sako Y, Sugimoto C, Onuma M. Expression of a major piroplasm surface
protein of Theileria sergenti in sporozoite stage. J Vet Med Sci. 1999;61(3):
275–7.
5. Sivakumar T, Hayashida K, Sugimoto C, Yokoyama N. Evolution and genetic
diversity of Theileria. Infect Genet Evol. 2014;27:250–63.
6. Eamens GJ, Gonsalves JR, Jenkins C, Collins D, Bailey G. Theileria orientalis
MPSP types in Australian cattle herds associated with outbreaks of clinical
disease and their association with clinical pathology findings. Vet Parasitol.
2013;191(3-4):209–17.
7. Kamau J, De Vos AJ, Playford M, Salim B, Kinyanjui P, Sugimoto C.
Emergence of new types of Theileria orientalis in Australian cattle and
possible cause of theileriosis outbreaks. Parasit Vectors. 2011;4:22.
8. Pulford DJ, McFadden A, Hamilton JS, Donald J. Investigation of the index
case herd and identification of the genotypes of Theileria orientalis
associated with outbreaks of bovine anaemia in New Zealand in 2012. N Z
Vet J. 2016;64(1):21–8.
9. Perera PK, Gasser RB, Anderson GA, Jeffers M, Bell CM, Jabbar A.
Epidemiological survey following oriental theileriosis outbreaks in Victoria,
Australia, on selected cattle farms. Vet Parasitol. 2013;197(3-4):509–21.
10. Aparna M, Ravindran R, Vimalkumar MB, Lakshmanan B, Rameshkumar P,
Kumar KG, Promod K, Ajithkumar S, Ravishankar C, Devada K et al. Molecular
characterization of Theileria orientalis causing fatal infection in crossbred
adult bovines of South India. Parasitol Int. 2011;60(4):524–9.
11. McFadden AM, Rawdon TG, Meyer J, Makin J, Morley CM, Clough RR, Tham
K, Mullner P, Geysen D. An outbreak of haemolytic anaemia associated with
infection of Theileria orientalis in naive cattle. N Z Vet J. 2011;59(2):79–85.
12. Eamens GJ, Bailey G, Jenkins C, Gonsalves JR. Significance of Theileria
orientalis types in individual affected beef herds in New South Wales based
on clinical, smear and PCR findings. Vet Parasitol. 2013;196(1-2):96–105.
13. Katzer F, Ngugi D, Oura C, Bishop RP, Taracha EL, Walker AR, McKeever DJ.
Extensive genotypic diversity in a recombining population of the
apicomplexan parasite Theileria parva. Infect Immun. 2006;74(10):5456–64.
14. Nkhoma SC, Nair S, Cheeseman IH, Rohr-Allegrini C, Singlam S, Nosten F,
Anderson TJ. Close kinship within multiple-genotype malaria parasite
infections. Proc Biol Sci. 2012;279(1738):2589–98.
15. Kubota S, Sugimoto C, Onuma M. Population dynamics of Theileria sergenti
in persistently infected cattle and vector ticks analysed by a polymerase
chain reaction. Parasitology. 1996;112(Pt 5):437–42.
16. Jenkins C, Micallef M, Alex SM, Collins D, Djordjevic SP, Bogema DR.
Temporal dynamics and subpopulation analysis of Theileria orientalis
genotypes in cattle. Infect Genet Evol. 2015;32:199–207.
17. Katzer F, Ngugi D, Walker AR, McKeever DJ. Genotypic diversity, a survival
strategy for the apicomplexan parasite Theileria parva. Vet Parasitol. 2010;
167(2-4):236–43.
18. Eamens GJ, Bailey G, Gonsalves JR, Jenkins C. Distribution and temporal
prevalence of Theileria orientalis major piroplasm surface protein types in
eastern Australian cattle herds. Aust Vet J. 2013;91(8):332–40.
19. Izzo M, Poe I, Horadagoda N, De Vos AJ, House JK. Haemolytic anaemia in
cattle in NSW associated with Theileria infections. Aust Vet J. 2010;88:45–51.
20. MacHugh ND, Connelley T, Graham SP, Pelle R, Formisano P, Taracha EL,
et al. CD8+ T-cell responses to Theileria parva are preferentially directed to a
single dominant antigen: Implications for parasite strain-specific immunity.
Eur J Immunol. 2009;39(9):2459–69.
21. Machugh ND, Burrells AC, Morrison WI. Demonstration of strain-specific CD8
T cell responses to Theileria annulata. Parasite Immunol. 2008;30(8):385–93.
22. Dobbelaere D, Heussler V. Transformation of leukocytes by Theileria parva
and T. annulata. Ann RevMicrobiol. 1999;53:1–42.
23. Sugimoto C, Kawazu S, Kamio T, Fujisaki K. Protein analysis of Theileria
sergenti/buffeli/orientalis piroplasms by two-dimensional polyacrylamide gel
electrophoresis. Parasitology. 1991;102(Pt 3):341–6.
24. Takemae H, Sugi T, Kobayashi K, Murakoshi F, Recuenco FC, Ishiwa A,
Inomata A, Horimoto T, Yokoyama N, Kato K. Analyses of the binding
between Theileria orientalis major piroplasm surface proteins and bovine red
blood cells. Vet Rec. 2014;175(6):149.
25. Onuma M, Kubota S, Kakuda T, Sako Y, Asada M, Kabeya H, Sugimoto C.
Control of Theileria sergenti infection by vaccination. Trop Anim Health Prod.
1997;29(4 Suppl):119S–23S.
26. Wang LX, Zhao JH, He L, Liu Q, Zhou DN, Zhou YQ, Zhao JL. An indirect
ELISA for detection of Theileria sergenti antibodies in water buffalo using a
recombinant major piroplasm surface protein. Vet Parasitol. 2010;170(3-4):
323–6.
27. Hammer JF, Jenkins C, Bogema DR, Emery D: Mechanical transfer of Theileria
orientalis: possible roles of biting arthropods, colostrum and husbandry
practices in disease transmission. Parasit Vectors 2016, In press.
28. Jenkins C, Wilton JL, Minion FC, Falconer L, Walker MJ, Djordjevic SP. Two
domains within the Mycoplasma hyopneumoniae cilium adhesin bind
heparin. Infect Immun. 2006;74(1):481–7.
29. Jenkins C, Samudrala R, Geary SJ, Djordjevic SP. Structural and functional
characterization of an organic hydroperoxide resistance protein from
Mycoplasma gallisepticum. J Bact. 2008;190(6):2206–16.
30. Bogema RD, Deutscher AT, Fell S, Collins D, Eamens GJ, Jenkins C.
Development and validation of a multiplexed hydrolysis probe qPCR assay
for the detection and quantification of Theileria orientalis and differentiation
of clinically-relevant subtypes. J Clin Microbiol. 2015;53(3):941–50.
31. Kawazu S, Sugimoto C, Kamio T, Fujisaki K. Antigenic differences
between Japanese Theileria sergenti and other benign Theileria species
of cattle from Australia (T. buffeli) and Britain (T. orientalis). Parasitol Res.
1992;78(2):130–5.
32. Iwasaki T, Kakuda T, Sako Y, Sugimoto C, Onuma M. Differentiation and
quantification of Theileria sergenti piroplasm types using type-specific
monoclonal antibodies. J Vet Med Sci. 1998;60(6):665–9.
33. Kawazu S, Sugimoto C, Kamio T, Fujisaki K. Molecular cloning and
immunological analysis of immunodominant piroplasm surface proteins of
Theileria sergenti and T. buffeli. J Vet Med Sci. 1992;54(2):305–11.
34. Casadevall A. Antibody-mediated immunity against intracellular pathogens:
two-dimensional thinking comes full circle. Infect Immun. 2003;71(8):4225–8.
35. Graham SP, Pelle R, Honda Y, Mwangi DM, Tonukari NJ, Yamage M, Glew EJ,
de Villiers EP, Shah T, Bishop R et al. Theileria parva candidate vaccine
antigens recognized by immune bovine cytotoxic T lymphocytes. Proc Natl
Acad Sci U S A. 2006;103(9):3286–91.
36. Magona JW, Walubengo J, Olaho-Mukani W, Jonsson NN, Welburn SC, Eisler
MC. Clinical features associated with seroconversion to Anaplasma
marginale, Babesia bigemina and Theileria parva infections in African cattle
under natural tick challenge. Vet Parasitol. 2008;155(3-4):273–80.
37. Hunfeld KP, Hildebrandt A, Gray JS. Babesiosis: recent insights into an
ancient disease. Int J Parasitol. 2008;38(11):1219–37.
Jenkins and Bogema Parasites & Vectors  (2016) 9:106 Page 8 of 9
38. Shimizu S, Suzuki K, Nakamura K, Kadota K, Fujisaki K, Ito S, Minami T.
Isolation of Theileria sergenti piroplasms from infected erythrocytes and
development of an enzyme-linked immunosorbent assay for serodiagnosis
of T sergenti infections. Res Vet Sci. 1988;45(2):206–12.
39. Shaw MK. The same but different: the biology of Theileria sporozoite entry
into bovine cells. Int J Parasitol. 1997;27(5):457–74.
40. Bock RE, Kingston TG, De Vos AJ. Effect of breed of cattle on transmission
rate and innate resistance to infection with Babesia bovis and B. bigemina
transmitted by Boophilus microplus. Aust Vet J. 1999;77(7):461–4.
41. Kiara H, Jennings A, Bronsvoort BM, Handel IG, Mwangi ST, Mbole-Kariuki M,
et al. A longitudinal assessment of the serological response to Theileria
parva and other tick-borne parasites from birth to one year in a cohort of
indigenous calves in western Kenya. Parasitology. 2014;141(10):1289–98.
42. Homer MJ, Aguilar-Delfin I, Telford 3rd SR, Krause PJ, Persing DH. Babesiosis.
ClinMicrobiol Rev. 2000;13(3):451–69.
43. Goddeeris BM, Morrison WI, Teale AJ, Bensaid A, Baldwin CL. Bovine
cytotoxic T-cell clones specific for cells infected with the protozoan parasite
Theileria parva: parasite strain specificity and class I major histocompatibility
complex restriction. Proc Natl Acad Sci U S A. 1986;83(14):5238–42.
44. Brown WC, Norimine J, Knowles DP, Goff WL. Immune control of Babesia
bovis infection. Vet Parasitol. 2006;138(1-2):75–87.
45. Kawamoto S, Takahashi K, Onuma M, Kubota S, Nejo H, Kurosawa T, Sonoda
M. Rebound phenomenon of parasitemia in splenectomized calves primarily
infected with Theileria sergenti. J Vet Med Sci. 1991;53(1):127–8.
46. Haselbarth K, Tenter AM, Brade V, Krieger G, Hunfeld KP. First case of human
babesiosis in Germany-Clinical presentation and molecular characterisation
of the pathogen. Int J Med Microbiol. 2007;297(3):197–204.
47. Krause PJ, Gewurz BE, Hill D, Marty FM, Vannier E, Foppa IM, Furman RR,
Neuhaus E, Skowron G, Gupta S et al. Persistent and relapsing babesiosis in
immunocompromised patients. Clin Infect Dis. 2008;46(3):370–6.
48. Tanaka M, Ohgitani T, Okabe T, Kawamoto S, Takahashi K, Onuma M,
Kawakami Y, Sasaki N. Protective effect against intraerythrocytic merozoites
of Theileria sergenti infection in calves by passive transfer of monoclonal
antibody. Nihon Juigaku Zasshi. 1990;52(3):631–3.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Jenkins and Bogema Parasites & Vectors  (2016) 9:106 Page 9 of 9
